Title |
Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunity
|
---|---|
Published in |
medRxiv, September 2021
|
DOI | 10.1101/2021.09.10.21262933 |
Pubmed ID | |
Authors |
Joseph J Sabatino, Kristen Mittl, William Rowles, Kira Mcpolin, Jayant V Rajan, Colin R Zamecnik, Ravi Dandekar, Bonny D Alvarenga, Rita P Loudermilk, Chloe Gerungan, Collin M Spencer, Sharon A Sagan, Danillo G Augusto, Jessa Alexander, Jill A Hollenbach, Michael R Wilson, Scott S Zamvil, Riley Bove |
X Demographics
The data shown below were collected from the profiles of 33 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 15 | 45% |
Italy | 2 | 6% |
Bahrain | 1 | 3% |
Pakistan | 1 | 3% |
United Kingdom | 1 | 3% |
Canada | 1 | 3% |
France | 1 | 3% |
India | 1 | 3% |
Ireland | 1 | 3% |
Other | 0 | 0% |
Unknown | 9 | 27% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 25 | 76% |
Scientists | 4 | 12% |
Practitioners (doctors, other healthcare professionals) | 3 | 9% |
Science communicators (journalists, bloggers, editors) | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 33 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 6 | 18% |
Student > Bachelor | 5 | 15% |
Other | 4 | 12% |
Student > Ph. D. Student | 1 | 3% |
Student > Doctoral Student | 1 | 3% |
Other | 2 | 6% |
Unknown | 14 | 42% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 6 | 18% |
Medicine and Dentistry | 6 | 18% |
Philosophy | 1 | 3% |
Nursing and Health Professions | 1 | 3% |
Immunology and Microbiology | 1 | 3% |
Other | 3 | 9% |
Unknown | 15 | 45% |